Trends in administrative prevalence of multiple sclerosis and utilization patterns of disease modifying drugs in Germany.
Holstiege J, Akmatov MK, Klimke K, Dammertz L, Kohring C, Marx C, Frahm N, Peters M, Ellenberger D, Zettl UK, Rommer PS, Stahmann A, Bätzing J.
Holstiege J, et al. Among authors: batzing j.
Mult Scler Relat Disord. 2022 Mar;59:103534. doi: 10.1016/j.msard.2022.103534. Epub 2022 Jan 22.
Mult Scler Relat Disord. 2022.
PMID: 35092945